Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
15.38
-0.22 (-1.44%)
Aug 14, 2025, 11:16 AM - Market open
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $561.16 million as of August 14, 2025. Its market cap has decreased by -33.44% in one year.
Market Cap
561.16M
Enterprise Value
320.78M
1-Year Change
-33.44%
Ranking
Category
Stock Price
15.38
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $561.16M, a decrease of -6.69%. That is a compound annual growth rate of -5.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 567.18M | -12.59% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |